Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Peptide Synthesis: Global Markets Projected to Reach $157.5 Billion by 2028, According to BCC Research Analysis

BCC_Research_Logo

News provided by

BCC Research LLC

May 02, 2024, 05:32 ET

Share this article

Share toX

Share this article

Share toX

Comprehensive Peptide Synthesis Report: Insights into Therapeutics and Nutraceuticals Usage for Disease Management

BOSTON, May 2, 2024 /PRNewswire/ -- According to the latest BCC Research study, the demand for Peptide Synthesis: Global Markets is growing from $90.1 billion in 2023 to $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% from 2023 through 2028.

The report on peptide synthesis covers everything from the types of peptides to their applications and how they're made. It's like a big picture of the market, including who's doing what, what's selling where, and what's coming up next. It's handy for businesses deciding what to make or invest in and for anyone interested in market trends. The report looks at the market from all angles - from cancer treatments to cosmetics - and breaks it down by regions, like North America and Asia-Pacific. It uses data from 2022 as a starting point and predicts where things are headed by 2028.

Meanwhile, the best-selling drug, Ozempic, will not be available until December 2024 due to high demand and limited production. At the same time, obesity is a silent killer that is increasingly affecting young people, leading to earlier onset of heart disease, and underscoring the urgent need for preventive measures.

To know more about Peptide Synthesis: Global Market Report, click here for details.

Key Drivers of Peptide Synthesis: Global Markets

Developments in Peptide Drug Delivery: Recent advances in drug delivery, such as sustained-release formulations and targeted systems, have improved the efficacy and patient compliance of peptide therapy. New techniques such as nanoparticles and microneedles promise further optimization.

Rising Prevalence of Chronic Diseases: The increase in the number of chronic diseases in the world creates the need for effective treatment. The peptide's specificity, minimal side effects, and pathway-modulating effects make it a promising candidate for the treatment of these diseases, especially as the population ages.

Increase in Biotech Spending: The biotech industry is investing heavily in peptide research and development to drive innovation and market growth. Companies, institutions, and pharmaceutical giants are allocating resources to peptide discovery, synthesis, and clinical trials, accelerating the development of peptide therapies.

Increase in Infectious and Chronic Diseases: Despite advances in treatment, infectious diseases persist, forcing the search for new treatments. Peptides provide a solution with their antimicrobial properties. In addition, peptides play an important role in the treatment of chronic diseases such as cancer and neurodegenerative diseases, demonstrating their versatility in addressing a variety of health problems.

Request a Sample Copy of the Peptide Synthesis: Global Markets Report.

Report Synopsis

Report Metrics

Details

Base year considered

2022

Forecast Period considered

2023-2028

Base year market size

$83.7 billion

Market Size Forecast

$157.5 billion

Growth Rate

CAGR of 11.8% for the forecast period of 2023-2028

Segment Covered

Type, Synthesis Type, Application, and Region

Regions covered

North America, Europe, Asia-Pacific, and Rest of the World

Countries covered

U.S., Mexico, Canada, Germany, France, U.K., Spain, Italy, China, Japan, India, Australia, and New Zealand, GCC countries, Brazil

Key Market Drivers

 

  • Developments in peptide drug delivery.
  • Rising prevalence of chronic diseases.
  • Increase in biotech spending.
  • Increase in infectious and chronic diseases

 

Segmentation Analysis:

Synthesis Types: Solid-phase synthesis can efficiently construct peptides on solid supports. Solution-phase synthesis offers flexibility but is less efficient for longer peptides. Mixed-phase synthesis combines both approaches to increase efficiency and flexibility.

Applications: In cosmetics, peptides can improve collagen and improve skin. Nutritional formulations use bioactive peptides to promote health. Peptides are also applicable in agriculture, food, and materials science.

Peptide Therapeutics: In cancer, peptides target specific pathways. In diabetes, they regulate insulin. In neurology, peptides can treat neurodegenerative diseases. They also show promise in cardiology and rare diseases.

Peptide Types: Synthetic peptides are specially designed. Antimicrobial peptides fight infections. Hormonal peptides regulate hormones. Bioactive peptides affect biology. Collagen peptides support skin and joints. Other professional categories serve specific purposes.Top of Form

This report on Peptide Synthesis: Global Market provides a comprehensive insight and analysis that addresses the following key questions:

Some of the Key Market Players Are:

  • ABBOTT
  • ABBVIE INC.
  • AMGEN INC.
  • ASTRAZENECA
  • BOEHRINGER INGELHEIM INTERNATIONAL GMBH
  • BRISTOL MYERS SQUIBB CO.
  • B. BRAUN SE
  • LILLY
  • MERCK & CO. INC.
  • MODERNA INC.
  • NOVARTIS AG
  • NOVO NORDISK A/S
  • SANOFI
  • TEVA PHARMACEUTICAL INDUSTRIES LTD.

Browse More Related Reports:

Biologic Therapeutic Drugs: Technologies and Global Markets: This report on the biologics market provides a comprehensive analysis of its current state and prospects. The report covers aspects such as competitive dynamics, regulatory environment, and market trends, providing an in-depth understanding of key players and market shares in various product categories such as therapeutic proteins, cell and gene therapies, and vaccines. It also examines market segmentation by application and source, along with a detailed regional analysis. The report uses 2022 as a base year and extends projections to 2028, all in constant dollars.

Global Market for Anti-obesity Drugs: The Anti-Obesity Drugs report provides an overview of the global market, analyzes trends, and forecasts CAGR from 2022 to 2028. Covers pharmaceutical types, distribution channels, and product lines of major companies. Market segmentation includes prescription and over-the-counter drugs distributed through hospitals, retail pharmacies, and online. The regions analyzed include North America, Europe, Asia Pacific, and the rest of the world.

Directly Purchase a copy of the report with BCC Research.

For further information or to make a purchase, please get in touch with [email protected].  

About BCC Research

BCC Research provides objective, unbiased measurement and assessment of market opportunities with detailed market research reports. Our experienced industry analysts' goal is to help you make informed business decisions, free of noise and hype.

Contact Us
Corporate HQ: 50 Milk St. Ste 16, Boston, MA 02109, USA
Email: [email protected],
Phone: +1 781-489-7301

For media inquiries, email [email protected] or visit our media page for access to our market research library.

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher.

Logo: https://mma.prnewswire.com/media/2183242/BCC_Research_Logo.jpg

SOURCE BCC Research LLC

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Anesthesia and Respiratory Devices Market to Hit $74.8 Billion by 2030

Anesthesia and Respiratory Devices Market to Hit $74.8 Billion by 2030

According to the latest study from BCC Research, the "Anesthesia and Respiratory Devices: Global Markets" is expected to grow from $51.9 billion in...

AI Revolutionizes Food Safety and Quality Control Market, Projected to Grow at a CAGR of 30.9%

AI Revolutionizes Food Safety and Quality Control Market, Projected to Grow at a CAGR of 30.9%

According to the latest study from BCC Research, the "AI in Food Safety and Quality Control Market" is projected to reach $13.7 billion by 2030,...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Pharmaceuticals

Pharmaceuticals

Biotechnology

Biotechnology

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.